DS
AGIO icon

David Shaw’s Agios Pharmaceuticals AGIO Stock Holding History

David Shaw’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,100
Closed -$656K – 4490
2025
Q4 		$656K Buy
+24,100
New +$846K ﹤0.01% 3792
2018
Q4 		– Sell
-12,000
Closed -$925K – 3727
2018
Q3 		$925K Hold
12,000
– – ﹤0.01% 2738
2018
Q2 		$1.01M Buy
+12,000
New +$1.05M ﹤0.01% 2696
2015
Q2 		– Sell
-10,000
Closed -$943K – 3724
2015
Q1 		$943K Hold
10,000
– – ﹤0.01% 2599
2014
Q4 		$1.12M Buy
+10,000
New +$893K ﹤0.01% 2745

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David Shaw's AGIO Position: Q2 2026 in Review

David Shaw increased its Agios Pharmaceuticals (AGIO) stake by 16% in Q2 2026, buying an estimated $12.9M and bringing the position to 3,107,005 shares worth $115M. The position accounts for 0.05% of the portfolio, ranked #395.

David Shaw first reported a position in AGIO in Q2 2014 and has held it in 41 quarters since. 236 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • David Shaw held 3,107,005 shares of Agios Pharmaceuticals worth $115M as of Q2 2026.
  • David Shaw bought 425,836 Agios Pharmaceuticals shares in Q2 2026, an estimated $12.9M.
  • Agios Pharmaceuticals made up 0.05% of David Shaw's portfolio in Q2 2026, its #395 holding.
  • David Shaw first reported a position in Agios Pharmaceuticals in Q2 2014 and has held it in 41 quarters since.
  • 236 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.